3 H]CE and total CE did not differ from those in wild-type MPM. Our results suggest that cPLA 2 s other than cPLA 2 a a contribute to the supply of fatty acids, which are utilized for the production of CE through the reesterification, in OxLDL-stimulated macrophages. However, the formation of foam cells could not be inhibited only by the suppression of cPLA 2 -mediated CE production.
Phospholipase A 2 (PLA 2 ) catalyzes the hydrolysis of the sn-2 ester bond in glycerophospholipids to generate nonesterified fatty acids and lysophospholipids. These products are known to act as second messengers for cellular signaling and as biologically active lipid mediators involved in homeostasis or various pathological conditions, mainly inflammatory diseases including atherosclerosis. 1) A number of PLA 2 isoforms have been identified in mammalian cells and tissues. 2, 3) Among them, secretory PLA 2 type II (sPLA 2 -II), a secretory PLA 2 isoform, and cytosolic PLA 2 a (cPLA 2 a, also known as PLA 2 type IVA), a cytosolic PLA 2 (cPLA 2 ) isoform, have been shown to increase in carotid atherosclerotic lesions. 4) sPLA 2 -II hydrolyzes phospholipids of apolipoprotein B-100-containing lipoproteins, such as low density lipoprotein (LDL), resulting in the accumulation of the modified lipoproteins within the intima. The sPLA 2 -II-modified lipoproteins are more susceptible to further enzymatic and oxidative modifications and to uptake by macrophages. 5, 6) Thus, sPLA 2 -II plays a critical role in the formation of atherosclerotic lesions. In contrast, roles of cPLA 2 s in atherogenesis are not yet completely elucidated.
In atherosclerotic lesions, the deposition of macrophagederived lipid-laden foam cells is associated with the accumulation of intracellular free cholesterol (FC) and cholesteryl ester (CE) resulting from the uptake of modified LDL, especially oxidized LDL (OxLDL), by macrophages. Normally, modified LDL is delivered to lysosomes for the hydrolysis of CE to FC and free fatty acid, which can be transported out of the lysosomes. Excess extralysosomal FC, because of its poor efflux, is reesterified to an acyl-CoA by the catalytic action of acyl-CoA:cholesterol acyltransferase (ACAT) and stored as CE in cytoplasm. 7, 8) Recently, we demonstrated that in [ 3 H]oleic acid-labeled mouse peritoneal macrophages (MPM) and RAW264.7 macrophages, methyl arachidonyl fluorophosphonate (MAFP), an inhibitor of cPLA 2 s, 9) suppressed the production of [ 10) Furthermore, we and other investigators showed that among cPLA 2 s isoforms, OxLDL promoted the hydrolytic action of cPLA 2 a in MPM. [10] [11] [12] These findings suggest that cPLA 2 s including cPLA 2 a are involved in the supply of free fatty acids, precursors for acyl-CoA required for the reesterification of FC. However, the roles of cPLA 2 s in the formation of foam cells remain unclear.
The formation of foam cells has been reported to be induced by LDLs undergoing modification including acetylation, oxidation, and aggregation in in vitro experiments. [13] [14] [15] [16] Acetylated LDL (AcLDL) can induce the formation of foam cells in association with the accumulation of CE. 17) Much more CE was produced through the reesterification of FC induced by AcLDL than that induced by OxLDL. 14, 18, 19) However, only OxLDL has been indicated to exist in atherosclerotic lesions and plasma, with OxLDL levels found to be higher in patients with coronary heart disease than in healthy subjects. 20) Furthermore, there are differences in the mechanisms of the formation of foam cells between OxLDL and AcLDL. OxLDL but not other modified LDLs including AcLDL induces lysosomal dysfunction through the inactivation of lysosomal proteases, and thereby the accumulation of CE in cytoplasm was not as great for OxLDL as for AcLDL. 21, 22) Considering this notion, it is unclear whether cPLA 2 -mediated production of CE through reesterification is involved in the formation of foam cells induced by OxLDL. In the present study, therefore, we examined the contribution of cPLA 2 s including cPLA 2 a to the production of CE and to the formation of foam cells in response to OxLDL using human acute monocytic leukemia (THP-1) cell-derived macrophages (THP-M) and MPM derived from cPLA 2 a-knockout (cPLA 2 a-KO) mice. , respectively. The affinity-purified rabbit polyclonal antibody against a peptide of cPLA 2 g was obtained from Oriental Yeast Co., Ltd., Tokyo, Japan.
MATERIALS AND METHODS

Materials
Cell Culture THP-1 cells were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, 100 mg/ml streptomycin, 2.5 mg/ml glucose, 2 mM GlutaMAX, 1 mM sodium pyruvate, and 10 mM HEPES (RPMI-medium) at 37°C under humidified air containing 5% CO 2 . THP-1 cells were plated in 24-well culture plates at 2ϫ10 5 cells, and cultured for 5 d in RPMI-medium containing 40 nM phorbol 12-myristate 13-acetate (PMA) to induce the differentiation into macrophages. The medium was changed every 2 d, and used throughout the experiments. The PMA-treated cells, used as THP-M, were treated with MAFP and stimulated with OxLDL or AcLDL as described in figure legends. For the preparation of MPM, 10% peptone was injected into the peritoneal cavity of wild-type or cPLA 2 a-KO mice in a C57BL/6 background. After 3 d, peritoneal cells were suspended in DMEM (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin and plated in 24-well culture plates at 4ϫ10 5 cells. The cells were incubated at 37°C for 3 h under humidified air containing 5% CO 2 . After being washed, the attached cells, as MPM, were further cultured for 12 h in fresh medium. MPM were placed in fresh medium, treated with MAFP, and stimulated with OxLDL or AcLDL as described in figure legends.
Preparation of OxLDL and AcLDL Commercial human LDL, prepared from plasma from multiple donors, was dialyzed against phosphate-buffered saline (PBS) at 4°C. The LDL (0.25 mg protein/ml) was oxidized by incubating with 5 mM CuSO 4 at 37°C for 3 h under air. The degree of oxidation of OxLDL was evaluated by measuring the concentration of thiobarbituric acid-reactive substances (TBARS). The OxLDL contained 20-30 nmol TBARS/mg protein. For the preparation of AcLDL, acetylation of LDL was performed by sequential addition of acetic anhydride into a mixture of 4 mg/ml LDL and 50% saturated sodium carbonate on ice.
22) The degree of the charge modification of OxLDL and AcLDL was monitored with agarose gel electrophoresis by Kyoto Biseibutsu Kenkyusyo (Kyoto, Japan). Construction of Expression Plasmids for Human cPLA 2 g g and Expression of cPLA 2 
g g in HEK293 Cells
The cDNA of the ORF of cPLA 2 g in pcDNA4/TO/cPLA 2 g 23) was amplified by polymerase chain reaction (PCR) with AmpliTaq Gold (Applied Biosystems) using as primers, 5Ј-GAA GAT CTA ACA TGG GAA GCT CTG AAG TTT-3Ј (sense) and 5Ј-GGA ATT CTA GCC TAT GCC AAG CAG CAA-3Ј (antisense). The BglII and EcoRI sites are underlined. After digestion with BglII and EcoRI, the PCR products were subcloned into the BglII-EcoRI sites of pIRES2-EGFP (a gift from Dr. E. Hirayama, Kyoto Pharmaceutical University) to yield a plasmid carrying a sequence corresponding to the native cPLA 2 g. HEK293 cells were transfected with pIRES2-EGFP (negative control) or pIRES2-EGFP/cPLA 2 g (positive control of cPLA 2 g), using lipofectamine 2000 (Invitrogen) and colonies of EGFP-expressing cells were chosen. Proteins of cPLA 2 g in the membrane fraction were detected by immunoblotting.
Immunoblot Analysis For the detection of cPLA 2 a, cPLA 2 g, and CD11b, cell lysate was solubilized with cell collection reagent (150 mM NaCl, 1% Nonidet P-40 (v/v), 0.5% sodium deoxycholate (w/v), 0.1% sodium dodecyl sulfate (w/v), protease inhibitors, and 50 mM Hepes, pH 7.4) as described elsewhere, 24) and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a 7.5% gel. Proteins were transferred to a nitrocellulose membrane, and then antibodies against cPLA 2 a (ϫ200), cPLA 2 g (ϫ200), or CD11b (ϫ500) were applied. The bound antibodies were visualized using a peroxidase-conjugated secondary antibody and Western blotting detection reagents (GE Healthcare BioScience).
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) The mRNA expression of cPLA 2 a and cPLA 2 g in MPM was analyzed by RT-PCR. Total RNA was extracted from MPM with ISOGEN (NIPPON GENE Co., Ltd., Tokyo, Japan). First-strand cDNA was generated from the total RNA in a reaction mixture containing random ninemers, dNTP, RNase inhibitor, and ReverTra Ace (TOYOBO, Co., Ltd., Osaka, Japan). The resulting reaction mixture was subjected to PCR with AmpliTaq Gold using 5Ј-CTC TGG TGT GAT GAA GGC ACT GTA TGA GTC-3Ј (sense) and 5Ј-ACG GCA GGT TAA ATG TGA GC-3Ј (antisense) for mouse cPLA 2 a (Gen Bank accession no. NM_008869), and 5Ј-AAG GAG CAG TTT CTC GAC CA-3Ј (sense) and 5Ј-TTG GCA GTA GTC TGC TGT GG-3Ј (antisense) for mouse cPLA 2 g (BC054740). Expression of b-actin was used as the internal standard. The PCR conditions were as follows: 94°C for 10 min; followed by 30 cycles (for b-actin) or 35 cycles (for cPLA 2 a and cPLA 2 g) of 95°C for 60 s, 60°C for 60 s, and 72°C for 150 s. Products were resolved on 1.5% agarose gels and visualized with ethidium bromide.
Determination of CE Content MPM or THP-M were stimulated with OxLDL for 12 h or 24 h, respectively, and washed with PBS. Lipids were extracted from the cells with hexane/2-propanol (3 : 2, v/v). CE was measured according to the method of Mizoguchi et al. For the analysis of lipids of MPM by TLC, a solvent (chloroform/methanol/acetic acid, 65 : 25 : 10, v/v/v) was used and allowed to run one-third of the length of the plate. After drying, the plate was developed again in the same direction with another solvent (petroleum ether/diethyl ether/acetic acid, 80 : 20 : 1, v/v/v). This solvent was allowed to run to the top of the plate. The area corresponding to CE, free fatty acid, phosphatidylcholine, or other lipids was scraped off, and the radioactivity was measured by liquid scintillation counting.
Oil Red O Staining Cells were fixed with 3.7% formaldehyde in PBS for 30 min, then washed twice with PBS. The cells were stained with 0.5% Oil Red O in 50% 2-propanol for 30 min, and then washed sequentially with 70% ethanol and PBS. The stained cells were photographed using a microscope (Olympus IX71) with a digital camera.
Statistical Analysis Values are expressed as the meanϮS.E.M. Data were analyzed with Student's t-test. pϽ0.05 was considered statistically significant.
RESULTS
Characterization of PMA-Differentiated THP-1 Macrophages and Modified LDL CD11b is a subunit of Mac-1, which has been identified as a specific marker of the differentiation of monocytes into macrophages, and increases with the differentiation. 26) Mac-1 is one of integrin family adhesion receptors that interact with ICAM-1 on endothelial cells, and is involved in the transendothelial migration of monocytes. 26, 27) We confirmed that when THP-1 cells were treated with 40 nM PMA for 6 d, the expression of CD11b increased time-dependently with a maximal increase 4-5 d after the treatment (Fig. 1A) . In this study, therefore, THP-1 cells treated with PMA for 5 d were used as THP-M. Under the conditions, while cPLA 2 a was detected in THP-1 cells, a transient increase in this isoform was observed during the treatment with PMA (Fig. 1A) . In contrast, we found that cPLA 2 g, known as cytosolic (intracellular) PLA 2 type IVC, was time-dependently increased by the treatment with PMA (Fig. 1A) . Thus, the expression of cPLA 2 a and cPLA 2 g was confirmed in THP-M.
The charge modification of OxLDL and AcLDL was monitored by agarose gel electrophoresis. The relative electrophoretic mobility of OxLDL and AcLDL was 2.3-2.6 and 3-3.5, respectively (Fig. 1B) .
Production of CE and Formation of Foam Cells Induced by OxLDL and AcLDL in THP-M and MPM As shown in Fig. 2 , stimulation of THP-M ( Fig. 2A) or MPM ( (Figs. 3A-k, -l) , while it had no effect on intracellular lipids in unstimulated cells (Figs. 3A-g, -h ). Furthermore, it is notable that the Oil Red O-staining patterns of intracellular lipids in OxLDL-stimulated THP-M differed from those in AcLDL-stimulated THP-M. The stained lipids in OxLDL-stimulated cells were relatively small and present around the nucleus, while the lipids in AcLDL-stimulated cells were relatively large and formed droplets in the cytoplasm. Such differences were more clearly observed in MPM stimulated with OxLDL (Figs. 3B-b , -e) and AcLDL (Figs.  3B-c, -f) . A few previous reports showed similar differences between OxLDL and AcLDL in macrophages. 14, 19) Effects of MAFP on the Production of CE and [ ]CE induced by OxLDL and AcLDL to the levels of unstimulated cells, although MAFP had no effect on the basal level (Fig. 4B) . These findings suggest that MAFP-sensitive cPLA 2 s are involved in the formation of CE that is produced through the reesterification of FC in response to OxLDL and AcLDL, but inhibition of cPLA 2 s has no effect on the increase in total intracellular levels of CE in OxLDL-stimulated cells. Furthermore, it is possible that the main source of CE accumulated in OxLDL-stimulated THP-M is not the reesterification of FC. (Fig. 5B ), but CE mass tended to slightly decrease (Fig. 5A) ) . Consequently, the present results suggest that fatty acids utilized for acyl chains of CE are supplied by the hydrolytic action of cPLA 2 a and/or cPLA 2 g in OxLDL-stimulated MPM (Fig. 5) and THP-M (Fig. 4) .
Effects of MAFP on the Production of CE and [ 3 H]CE Induced by OxLDL in MPM We further examine the
Production of CE and [ 3 H]CE Induced by OxLDL in cPLA 2 a a-KO MPM To examine the possible involvement of cPLA 2 a in the production of CE, MPM derived from cPLA 2 a-KO mice were used. We found, however, that OxLDL (50 mg/ml) increased the mass of CE and [ 3 H]CE in cPLA 2 a-KO MPM, as shown in Fig. 6A and B. The degree of augmentation of CE did not differ between the MPM derived from cPLA 2 a-KO and wild-type mice, while the production of [ 3 H]CE was much greater in cPLA 2 a-KO MPM than in wild-type MPM. Furthermore, the Oil Red O-staining patterns of intracellular lipids in cPLA 2 a-KO MPM stimulated with OxLDL did not differ from those in wild-type MPM (Fig. 6C) . In cPLA 2 a-KO MPM, no expression of cPLA 2 a protein and mRNA was detected (Figs. 6D, E) . 24) it is possible that cPLA 2 g is involved in the supply of fatty acids utilized for the production of CE. To confirm the expression of cPLA 2 g in MPM, cPLA 2 g mRNA was examined by RT-PCR. The result indicates that cPLA 2 g mRNA was expressed in MPM derived from cPLA 2 a-KO mice as well as wild-type mice (Fig. 6E) .
DISCUSSION
The earliest atherosclerotic lesion is the fatty streak, which consists of an aggregation of lipid-rich macrophage-derived foam cells and T-lymphocytes within the innermost layer of the arterial wall. 28) Fatty streaks are high in CE and high in cholesteryl oleate compared with their cholesteryl linoleate content, while plasma LDL contains more cholesteryl linoleate than cholesteryl oleate. 29, 30) It is conceivable that oleic acid, as an acyl chain of cholesteryl oleate produced in foam cells, is derived from cellular lipids, so it is effective at preventing the development of fatty streaks to inhibit the production of CE by suppressing the supply of fatty acids, precursors for acyl-CoA, from cellular lipids. In fact, triacsin C, an inhibitor of acyl-CoA synthetase, has been shown to inhibit the formation of foam cells induced by FC-rich liposomes in vitro. 31) Previously, we and other investigators re- ported that the acyl chains utilized for the production of CE are derived from cellular phospholipids. 10, 32) The present study, therefore, examined the possible contribution of cPLA 2 s including cPLA 2 a and cPLA 2 g to the supply of fatty acids utilized for the production of CE and to the formation of foam cells.
The present study showed that OxLDL promoted the production of [ 3 H]CE in both THP-M and MPM, and the production was significantly suppressed by MAFP, an inhibitor of cPLA 2 a, cPLA 2 g, and iPLA 2 s (Figs. 4, 5) (Fig. 5) . These findings are consistent with the results of our previous study with OxLDL-stimulated RAW264.7 macrophages and mouse resident peritoneal macrophages. 10) Considering that an inhibitor of iPLA 2 s had no effect on OxLDL-induced production of CE, 10) it is possible that free fatty acids utilized as acyl chains of CE are supplied, at least in part, through the hydrolysis of cellular phospholipids catalyzed by cPLA 2 a and/or cPLA 2 g. The activation of cPLA 2 a is regulated by phosphorylation and by a calcium-dependent translocation from the cytosol to the membranes. 33) In cPLA 2 a-overexpressing CHO cells, 25-hydroxycholesterol, an oxysterol present in OxLDL particles, induces the release of arachidonic acid and the translocation of the enzyme to the membranes. 12) Recently, we also reported that cPLA 2 a translocates to the membranes in MPM upon stimulation with OxLDL.
11) Based on these findings indicating that OxLDL activates cPLA 2 a, it is possible that this enzyme participates in the production of CE. However, we found here that the production of [ 3 H]CE and accumulation of total CE mass induced by OxLDL did not differ between the MPM derived from cPLA 2 a-KO and wild-type mice (Fig. 6) . Our results suggest that cPLA 2 a does not contribute to the supply of free fatty acids utilized as acyl chains of CE. In the atherosclerotic lesions, foam cells contain more cholesteryl oleate (50%) than cholesteryl arachidonate (3%). 30) This also suggests a lack of contribution of cPLA 2 a to the production of CE, because cPLA 2 a preferentially hydrolyzes glycerophospholipids bearing an arachidonoyl residue at the sn-2 position. Other PLA 2 s including cPLA 2 g do not exhibit such a preference. While cPLA 2 a was expressed ubiquitously in the body, cPLA 2 g was expressed in heart, skeletal muscle, brain, 34) and monocytes from peripheral blood. 35) We also showed here that cPLA 2 g was expressed in MPM as well as THP-M (Figs. 1, 6 ). Furthermore, in contrast to cPLA 2 a, cPLA 2 g is located in membrane fractions, 23) especially in the endoplasmic reticulum, 36) in which ACAT is also located.
37)
Considering these findings and our results that MAFP inhibited OxLDL-induced production of [ 3 H]CE in not only THP-M and wild-type MPM (Figs. 3, 5 ) but also cPLA 2 a-KO MPM (data not shown), all of which expressed cPLA 2 g (Figs. 1, 6 ), it could be assumed that cPLA 2 g is involved in the MAFP-sensitive production of [ 3 H]CE. To clarify this possibility, further studies with cPLA 2 g-knockdown THP-M are needed.
The CE within OxLDL taken up by macrophages is digested to FC and free fatty acid in lysosomes. The FC is reesterified by the catalytic action of ACAT to form CE, which is accumulated in the cytoplasm to protect cells from the toxicity of FC. However, the excessive uptake of modified LDL, especially OxLDL, leads to the formation of foam cells with dysfunctional lysosomes and the deposition of CE in lysosomes 38) or induces apoptosis through damage of the endoplasmic reticulum with the accumulation of FC. 39) Regarding targets to suppress the formation of foam cells, ACAT is considered one. Although an inhibitor of ACAT actually suppressed the reesterification of FC, 40) suppression of ACAT results in the accumulation of intracellular FC, as shown in ACAT-deficient macrophages upon stimulation with AcLDL. 41) In fact, an ACAT inhibitor did not inhibit the formation of foam cells induced by FC-rich liposomes. 31) Similarly, hypercholesterolemic LDL receptor-knockout mice reconstituted with ACAT-deficient macrophages developed larger atherosclerotic lesions than control LDL receptor-knockout mice. 42) Thus, ACAT contributes to the reesterification of FC, but its suppression causes the accumulation of FC followed by the formation of foam cells and/or FC-in- The expected sizes of products of RT-PCR are indicated. As a negative control experiment (N), total RNA extracted from wild-type macrophages was subjected to reverse transcription in the absence of reverse transcriptase followed by PCR. The resulting reaction mixture was also resolved on agarose gels. duced cytotoxicity. Consistent with the lack of an effect of ACAT inhibition on the formation of foam cells, the present study showed that MAFP did not inhibit the formation of foam cells or the increase in intracellular total CE induced by OxLDL, despite a significant suppression of the increase in [ 3 H]CE, which was produced through the reesterification of FC, in THP-M and MPM (Figs. 3-5) . The lack of inhibition may be explained by the following: (1) Acyl-CoA used to form CE is supplied not only from cPLA 2 -mediated release of free fatty acids but also from other pathways. (2) The formation of foam cells with an increase in CE content upon the OxLDL stimulation is predominantly mediated by the deposition of CE derived from OxLDL in lysosomes rather than the accumulation of CE through the reesterification of FC in cytoplasm. In other words, the contribution of CE produced through the reesterification to the deposition of intracellular CE is not major upon stimulation with OxLDL. This latter notion is supported by the previous finding that the lysosomal CE and FC derived from OxLDL are not as easily cleared as those derived from AcLDL, thus being accumulated within lysosomes in THP-1-derived macrophages.
15)
The difference between OxLDL and AcLDL is consistent with the present results that Oil Red O-stained lipids in OxLDL-stimulated THP-M and MPM were relatively small and present around the nucleus, while the lipids in AcLDLstimulated cells were relatively large and formed droplets in cytoplasm (Fig. 3) . Consequently, it is conceivable that the reduction in the amounts of CE and FC deposited in lysosomes is important to prevent the formation of foam cells in response to OxLDL. However, considering that the amount of FC deposited intracellularly upon stimulation with OxLDL can be reduced in the presence of a certain cholesterol acceptor in the extracellular medium, 15) inhibition of CE production through the reesterification of FC might be effective in preventing the formation of foam cells when the pathways of FC efflux function efficiently.
In conclusion, on the basis of the present results, we suggest that MAFP-sensitive cPLA 2 s, probably cPLA 2 g but not cPLA 2 a, are involved, in part, in the supply of fatty acids utilized for the reesterification of FC to produce CE in OxLDLstimulated THP-M and MPM. Furthermore, with regard to the formation of foam cells induced by OxLDL, the contribution of CE produced through reesterification is not as great as that of CE deposited in lysosomes. Taking this into account, to evaluate the roles of cPLA 2 g in the formation of foam cells, further experiments under conditions where cPLA 2 g-knockdown cells are stimulated in the presence of cholesterol acceptors, such as apolipoprotein A-I and high density lipoprotein, are underway in our laboratory.
